Nuclera gains £1.14m funding from Innovate UK

Betsy Goodfellow | June 7, 2024 | News story | Research and Development Innovate UK, Nuclera, Pharmacy, grants 

Nuclera has announced that it has been awarded two grants from Innovate UK, totalling £1.14m.

The funding comprises of a £790,000 flexible, agile, scalable and sustainable technologies (FASST) grant awarded in collaboration with DeepMirror, and a £350,000 Engineering Biology grant.

The FASST grant makes up part of the Innovate UK Transforming Medicines Manufacturing (TMM) programme, and is intended to support and grow the UK’s capabilities in medicines manufacturing through the development of first-of-a-kind technologies in order to accelerate patient access to new drugs and treatments.

Nuclera is one of 48 companies that have been given the Engineering Biology grant, intended to use engineering biology to combat various challenges within the health, environment, food production and sustainability industries.

Dr Michael Chen, chief executive officer and co-founder at Nuclera, commented: “Receiving both grants from Innovate UK is testament to the power of eProtein Discovery and demonstrates that Nuclera has the technical innovation to address global unmet challenges in the fields of manufacturing and engineering biology. We look forward to working with DeepMirror, Dr Beis (via Imperial Consultants), and Dr Quigley from Diamond Light Source on both projects.”

Betsy Goodfellow

Related Content

shutterstock_244903099

“Game-changing” osteoarthritis drug receives £675k funding from Innovate UK

A novel and potentially “game-changing” oral therapy for the treatment of osteoarthritis (OA) has received …

4768764591_9e4f7f0eb8_z

EU rules may be stifling Britain’s biotech industry

EU rules are stifling Britain’s biotech industry, according to companies who talked to British newspaper …

flu_vaccine

Emergex secures funds in race to develop universal flu vaccine

UK-based biotech, Emergex Vaccines, has received £1 million to push its universal flu vaccine through …

Latest content